SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-19-001703
Filing Date
2019-02-01
Accepted
2019-02-01 16:30:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G nach20190131_sc13g.htm SC 13G 58432
  Complete submission text file 0001437749-19-001703.txt   59784
Mailing Address 101 WESTCOTT SUITE 603 HOUSTON TX 77007
Business Address
CHANG NANCY T (Filed by) CIK: 0001135041 (see all company filings)

Type: SC 13G

Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90788 | Film No.: 19560194
SIC: 2834 Pharmaceutical Preparations